glp-1 and ulcerative colitis The Potential for GLP-1s in the Treatment of GLUCAGON-LIKE 1 RECEPTOR AGONIST USE

Binge eating disorder (BED) is characterized by recurring episodes of uncontrollable overeating, often marked by consuming large amounts of food rapidly and to the point of discomfort

L.ZhongW.ShuJ.Abu MuchA.LotanD.GrupperA.et al (2021)

New England Journal of Medicine, 375 ,

Purpose-built for physicians Pharmacology Consult Pharmacology Consult: GLP-1 receptor agonists for weight loss management Pharmacology Consult Key takeaways: GLP-1 receptor agonists are associated with significant weight loss in patients with obesity

Diabetic kidney disease, a common complication in patients with type 2 diabetes mellitus, is associated with a markedly increased morbidity and mortality, especially of cardiovascular origin, and faster progression to end-stage renal disease

Common Side Effects 7